Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
ObjectiveNarcolepsy, a rare neurological disorder believed to have an autoimmune etiology, necessitates lifelong management. This study aimed to provide evidence supporting the safety of pharmacological treatment for narcolepsy.MethodsFive-year data on pitolisant, sodium oxybate, solriamfetol, and m...
Saved in:
Main Authors: | Xiaodan Zhou (Author), Jia Chen (Author), Bangtian Xu (Author), Li Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority metaanalytical approach
by: Philippe Lehert, et al.
Published: (2020) -
Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol
by: Stéphane Krief, et al.
Published: (2021) -
Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
by: Romigi A, et al.
Published: (2018) -
Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy
by: Cuiping Chen, et al.
Published: (2020) -
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary
by: Thomas Roth, et al.
Published: (2023)